Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE

被引:9
|
作者
Nakamuta, Makoto [1 ]
Kotoh, Kazuhiro [1 ]
Enjoji, Munechika [1 ]
Nawata, Hajime [1 ]
机构
[1] Kyushu Univ, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
Hepatocyte; Fibril-collagen; Fixed collagen;
D O I
10.3748/wjg.v11.i15.2264
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are central to the spontaneous resolution of liver fibrosis. The mechanisms involved have been investigated in hepatic stellate cells (HSC), but not in hepatocytes. We investigated the effects of fibril-and fixed-collagen on MMP-1 and TIMP-1 production in hepatocytes, using the HLE cell line. METHODS: Fibril type I and IV collagen were prepared by HCl digestion of type I and IV collagen, respectively. For fixed-collagen, culture dishes were coated with fibril type I or IV collagen and fixed by ultraviolet. Type I collagenase activity was measured using fluorescein isothiocyanate-labeled type I collagen. MMP-1 and TIMP-1 in HLE cells were measured by a one-step sandwich enzyme immunoassay. RESULTS: Both fibril type I and IV collagen significantly increased type I collagenase activity about two-fold compared with no fibril collagen. The effects of the fibril collagen were not affected by the coating condition. There was no significant difference in the effects on collagenase activity between cells cultured in medium containing fibril type I collagen and those cultured in the presence of type IV collagen. Both types of fibril collagen significantly increased MMP-1 production, and showed more than 10-fold higher levels of MMP-1 than the control. The enhanced MMP-1 production by fibril collagens was unaffected by the coating condition. By contrast, TIMP-1 production was not changed by the addition of fibril type I or IV collagen, and neither was it affected by the coating conditions. Coating with type I collagen significantly suppressed MMP-1 production by almost one-tenth compared with no coating. By contrast, TIMP-1 production was not affected by either the absence of a collagen coat or by increasing the concentration of the coating collagen. CONCLUSION: These results indicated that, in HLE cells, fibril-and fixed-collagen have opposite effects on MMP-1 production without affecting TIMP production. Fibril collagen induced collagenase activity by up-regulation of MMP-1 production without affecting TIMP-1 production. By contrast, fixed collagen reduced MMP-1 production. Our results suggest that hepatocytes might also play an important role in the regulation of the hepatic fibrosis alongside HSC. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:2264 / 2268
页数:5
相关论文
共 50 条
  • [41] Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma
    Berend, KR
    Toth, AP
    Harrelson, JM
    Layfield, LJ
    Hey, LA
    Scully, SP
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (01): : 11 - 17
  • [42] Effects of (-)-epigallocatechin-3-gallate on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibroblasts irradiated with ultraviolet A
    宋秀祖
    夏济平
    毕志刚
    中华医学杂志(英文版), 2004, (12) : 79 - 82
  • [43] Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1
    Tüter, G
    Kurtis, B
    Serdar, M
    JOURNAL OF PERIODONTOLOGY, 2002, 73 (05) : 487 - 493
  • [44] The effects of pulse methylprednisolone on matrix metalloproteinase and tissue inhibitor of metalloproteinase-1 expression in rheumatoid arthritis
    Wong, P
    Cuello, C
    Bertouch, JV
    Roberts-Thomson, PJ
    Ahern, MJ
    Smith, MD
    Youssef, PP
    RHEUMATOLOGY, 2000, 39 (10) : 1067 - 1073
  • [45] Evaluation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 levels in gingival fibroblasts of cyclosporin A-treated patients
    Tüter, G
    Serdar, MA
    Yalim, M
    Gürhan, IS
    Balos, K
    JOURNAL OF PERIODONTOLOGY, 2002, 73 (11) : 1273 - 1278
  • [46] Effect of Danshao Huaxian capsule on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibrotic liver of rats
    Yang, Qin
    Xie, Ru-Jia
    Geng, Xiao-Xia
    Luo, Xin-Hua
    Han, Bing
    Cheng, Ming-Liang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (32) : 4953 - 4956
  • [48] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis
    Szamatowicz, J
    Laudanski, P
    Tomaszewska, I
    HUMAN REPRODUCTION, 2002, 17 (02) : 284 - 288
  • [49] Matrix metalloproteinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
    Derosa, Giuseppe
    D'Angelo, Angela
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    Pricolo, Fabio
    Salvadeo, Sibilla
    Montagna, Lorenza
    Gravina, Alessia
    Ferrari, Ilaria
    Galli, Simona
    Paniga, Sonia
    Tinelli, Carmine
    Cicero, Arrigo F. G.
    ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2006, 13 (03): : 227 - 231
  • [50] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    AMERICAN HEART JOURNAL, 2006, 152 (01)